41
Investigation of Serious Adverse Events Following Vaccination Against Yellow Fever: Emphasis on Genetic Basis and Biological Markers
Condition(s):Drug-Related Side Effects and Adverse ReactionsLast Updated:May 13, 2019Unknown status
Yellow Fever: 55 Clinical Trials, Page 5 of 6
Hide Studies Not Open or Pending
42
Training Study to Characterize Biomarkers to Chickenpox and Yellow Fever Vaccines
Condition(s):HealthyLast Updated:February 16, 2015Completed
43
Yellow Fever Vaccination Under Low Dose Methotrexate Therapy
Condition(s):Rheumatic; Dermatologic DisordersLast Updated:March 9, 2015Unknown status
44
Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in Adults
Condition(s):DengueLast Updated:October 8, 2020Completed
45
Yellow Fever Vaccine in Patients With Rheumatic Diseases
Condition(s):Systemic Lupus; Rheumatoid Arthritis; Spondyloarthritis; Inflammatory Myopathy; Systemic Sclerosis; Mixed Connective Tissue Disease; Takayasu Arteritis; Granulomatosis With Polyangiitis; Sjogren’s Syndrome; Juvenile Idiopathic Arthritis; Juvenile DermatomyositisLast Updated:April 26, 2019Completed
46
Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
Condition(s):Atopic DermatitisLast Updated:January 13, 2014Completed
47
Immunogenicity and Safety Study of GSK Biologicals’ Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.
Condition(s):Malaria; Malaria VaccinesLast Updated:September 29, 2021Completed
48
Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection
Condition(s):Endoplasmic Reticulum Stress; Viral Infection; Yellow FeverLast Updated:May 12, 2022Recruiting
49
Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects
Condition(s):Dengue; Dengue Fever; Dengue Hemorrhagic Fever; Dengue VirusLast Updated:February 27, 2018Completed
50
Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Condition(s):Dengue Virus; Dengue Fever; Dengue Hemorrhagic Fever; Dengue DiseasesLast Updated:April 5, 2022Completed